/PRNewswire/ The rapid microbiology testing market is expected to develop at a 9.4% CAGR from 2024 to 2034, reaching US$ 12.2 billion by 2034, up from US$ 5..
/PRNewswire/ Scanbase, an innovative computer vision company, is spearheading the transformation of at-home healthcare through cutting-edge computer vision.
Global rapid microbiology testing market is likely to witness the highest CAGR of 9.24% from 2023-2031. The market revenue was US$ 4.3 billion in 2022 and
/PRNewswire/ The "Home Diagnostics Markets. Strategies and Trends. Forecasts by Application by Channel by Technology and by Country. With Market Analysis.